325 related articles for article (PubMed ID: 29346446)
1. Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.
Agah E; Zardoui A; Saghazadeh A; Ahmadi M; Tafakhori A; Rezaei N
PLoS One; 2018; 13(1):e0190252. PubMed ID: 29346446
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of CSF multiple assay in multiple sclerosis: A single center experience.
De Fino C; Lucchini M; Lucchetti D; Nociti V; Losavio FA; Bianco A; Colella F; Ricciardi-Tenore C; Sgambato A; Mirabella M
Mult Scler Relat Disord; 2019 Oct; 35():176-181. PubMed ID: 31394405
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.
Tortorella C; Direnzo V; Ruggieri M; Zoccolella S; Mastrapasqua M; D'Onghia M; Paolicelli D; Cuonzo FD; Gasperini C; Trojano M
Mult Scler; 2018 Jul; 24(8):1039-1045. PubMed ID: 28537100
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin in the Cerebrospinal Fluid of Patients with Severe Aneurysmal Subarachnoid Hemorrhage.
Abate MG; Moretto L; Licari I; Esposito T; Capuano L; Olivieri C; Benech A; Brucoli M; Avanzi GC; Cammarota G; Dianzani U; Clemente N; Panzarasa G; Citerio G; Carfagna F; Cappellano G; Della Corte F; Vaschetto R
Cells; 2019 Jul; 8(7):. PubMed ID: 31295895
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
Kivisäkk P; Healy BC; Francois K; Gandhi R; Gholipour T; Egorova S; Sevdalinova V; Quintana F; Chitnis T; Weiner HL; Khoury SJ
Mult Scler; 2014 Apr; 20(4):438-44. PubMed ID: 24005026
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin levels are associated with late-time lower regional brain volumes in multiple sclerosis.
Orsi G; Hayden Z; Cseh T; Berki T; Illes Z
Sci Rep; 2021 Dec; 11(1):23604. PubMed ID: 34880402
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
[TBL] [Abstract][Full Text] [Related]
10. A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis.
Sun M; Liu N; Xie Q; Li X; Sun J; Wang H; Wang M
Mult Scler Relat Disord; 2021 Jun; 51():102870. PubMed ID: 33819724
[TBL] [Abstract][Full Text] [Related]
11. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients.
Bai Z; Chen D; Wang L; Zhao Y; Liu T; Yu Y; Yan T; Cheng Y
Front Neurosci; 2019; 13():1026. PubMed ID: 31636528
[No Abstract] [Full Text] [Related]
13. Could Osteopontin be a useful biomarker in the diagnosis and severity assessment of osteoarthritis? A systematic review and meta-analysis of recent evidence.
Abdelnaby R; Sonbol YT; Dardeer KT; ELgenidy A; Ebrahim MA; Elmenawi KA; Abdallah AA; Ballut OO; Metwally SA; Arafat MS; Elsayed M; Abouelhamd AM; Farahat RA; Karkour AM; Mohamed KA; Rauen T
Clin Immunol; 2023 Jan; 246():109187. PubMed ID: 36403917
[TBL] [Abstract][Full Text] [Related]
14. Plasma osteopontin levels in multiple sclerosis.
Comabella M; Pericot I; Goertsches R; Nos C; Castillo M; Blas Navarro J; Río J; Montalban X
J Neuroimmunol; 2005 Jan; 158(1-2):231-9. PubMed ID: 15589058
[TBL] [Abstract][Full Text] [Related]
15. Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis.
Ning L; Wang B
PLoS One; 2022; 17(9):e0274565. PubMed ID: 36103562
[TBL] [Abstract][Full Text] [Related]
16. The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis?
Altintaş A; Saruhan-Direskeneli G; Benbir G; Demir M; Purisa S
J Neurol Sci; 2009 Jan; 276(1-2):41-4. PubMed ID: 18845306
[TBL] [Abstract][Full Text] [Related]
17. Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis.
Braitch M; Nunan R; Niepel G; Edwards LJ; Constantinescu CS
Arch Neurol; 2008 May; 65(5):633-5. PubMed ID: 18474739
[TBL] [Abstract][Full Text] [Related]
18. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
Jafarinia M; Sadeghi E; Alsahebfosoul F; Etemadifar M; Jahanbani-Ardakani H
Int J Neurosci; 2020 May; 130(5):493-498. PubMed ID: 31795798
[No Abstract] [Full Text] [Related]
20. Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
Szalardy L; Zadori D; Simu M; Bencsik K; Vecsei L; Klivenyi P
J Neurol Sci; 2013 Aug; 331(1-2):38-42. PubMed ID: 23706476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
